Creutzfeldt-Jakob disease in Hungary.

Human prion diseases or transmissible spongiform encephalopathies are progressive fatal neuropsychiatric diseases. In addition to the evaluation of clinical features, a common diagnostic procedure includes examination of the protein 14-3-3 in the cerebrospinal fluid, performing EEG to detect periodic sharp wave complexes with triphasic morphology, and cranial MRI to demonstrate high signal intensity in the basal ganglia or thalamus. The definite diagnosis requires a neuropathological examination. The analysis of the prion protein gene (PRNP) is initiated mainly after suspicion of a positive family history or an atypical presentation. In Hungary collecting data and setting up the neuropathological diagnosis in suspect prion disease cases originates from the late 1960s. Systematic surveillance was established in 1994 and since 2001 reporting of Creutzfeldt-Jakob disease has been compulsory. According to our database, the incidence of genetic prion disease is increased in Hungary. The most frequent mutation in the PRNP is at codon 200. This might be linked to migration from the Slovakian focus. Acquired forms of prion disease were not detected in our country. The surveillance system is based on referrals from clinicians and pathologists and the aim is to perform the neuropathological examination and analysis of the PRNP on the majority of suspect cases.

[1]  J. Minárovits,et al.  Increased incidence of genetic human prion disease in Hungary , 2005, Neurology.

[2]  A. Aguzzi,et al.  Genetic prion disease: the EUROCJD experience , 2005, Human Genetics.

[3]  Horst Urbach,et al.  MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. , 2005, Brain : a journal of neurology.

[4]  G. Sobue,et al.  Neuropathologic characteristics of brainstem lesions in sporadic Creutzfeldt-Jakob disease , 2005, Acta Neuropathologica.

[5]  M. Equestre,et al.  High incidence of genetic human transmissible spongiform encephalopathies in Italy , 2005, Neurology.

[6]  A. Aguzzi,et al.  Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada , 2005, Neurology.

[7]  岩崎 靖 Neuropathologic characteristics of brainstem lesions in sporadic Creutzfeldt-Jakob disease , 2005 .

[8]  A. Aguzzi,et al.  Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. , 2004, Brain : a journal of neurology.

[9]  H. Budka,et al.  Rationale for diagnosing human prion disease , 2004, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[10]  E. Mitrová Some new aspects of CJD epidemiology in Slovakia , 1991, European Journal of Epidemiology.

[11]  A. Korczyn,et al.  Creutzfeldt-Jacob disease associated with the PRNP codon 200LYS mutation: An analysis of 45 families , 1991, European Journal of Epidemiology.

[12]  H. Budka,et al.  Contribution of neuropathology to the understanding of human prion disease. , 2004, Folia neuropathologica.

[13]  H. Budka,et al.  Molecular classification of sporadic Creutzfeldt-Jakob disease. , 2003, Brain : a journal of neurology.

[14]  H. Budka,et al.  Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease , 2003, Acta Neuropathologica.

[15]  H. Budka,et al.  Immunohistochemistry for the Prion Protein: Comparison of Different Monoclonal Antibodies in Human Prion Disease Subtypes , 2002, Brain pathology.

[16]  G. Belay,et al.  Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. , 2002, Acta virologica.

[17]  H. Budka,et al.  Mutations of the prion protein gene phenotypic spectrum. , 2002, Journal of neurology.

[18]  H. Budka,et al.  Inherited prion disease with A117V mutation of the prion protein gene: a novel Hungarian family , 2001, Journal of neurology, neurosurgery, and psychiatry.

[19]  H. Budka,et al.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2000, Neurology.

[20]  P. Brown,et al.  A three-sister sibship of Gerstmann-Sträussler-Scheinker disease with a CJD phenotype , 2000, Neurology.

[21]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[22]  P Brown,et al.  Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. , 1999, American journal of human genetics.

[23]  M. Pocchiari,et al.  High incidence of Creutzfeldt-Jakob disease in rural Calabria, Italy , 1998, The Lancet.

[24]  K. Kosaka,et al.  Japanese Creutzfeldt-Jakob disease patients exhibiting high incidence of the E200K PRNP mutation and located in the basin of a river. , 1998, Neurological research.

[25]  I. Ghorayeb,et al.  Creutzfeldt-Jakob disease with long duration and panencephalopathic lesions: Molecular analysis of one case , 1998, Neurology.

[26]  S. Prusiner,et al.  Prion diseases and the BSE crisis. , 1997, Science.

[27]  S. Prusiner,et al.  Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews. , 1997, Medicine.

[28]  J. Chapman,et al.  The risk of developing Creutzfeldt‐Jakob disease in subjects with the PRNP gene codon 200 point mutation , 1994, Neurology.

[29]  P. Brown,et al.  Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia , 1990, The Lancet.

[30]  T. Mizutani Panencephalopathic type of Creutzfeldt-Jakob disease , 1985 .

[31]  E. Mitrová,et al.  CLUSTER OF CREUTZFELDT-JAKOB DISEASE AND PRESENILE DEMENTIA , 1977, The Lancet.

[32]  M. Alter,et al.  Creutzfeldt-Jakob Disease: Focus among Libyan Jews in Israel , 1974, Science.